These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 22558378)

  • 1. Protective efficacy of neutralizing monoclonal antibodies in a nonhuman primate model of Ebola hemorrhagic fever.
    Marzi A; Yoshida R; Miyamoto H; Ishijima M; Suzuki Y; Higuchi M; Matsuyama Y; Igarashi M; Nakayama E; Kuroda M; Saijo M; Feldmann F; Brining D; Feldmann H; Takada A
    PLoS One; 2012; 7(4):e36192. PubMed ID: 22558378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and characterization of two GP-specific monoclonal antibodies, which synergistically protect non-human primates against Ebola lethal infection.
    Shcheblyakov D; Esmagambetov I; Simakin P; Kostina L; Kozlov A; Tsibezov V; Grebennikova T; Chifanov D; Rumyantseva I; Boyarskaya N; Sizikova T; Shagarova N; Andrus А; Shatohina I; Syromyatnikova S; Kovalchuk A; Pantyukhov V; Borisevich S; Zubkova O; Tukhvatulin A; Logunov D; Naroditsky B; Gintsburg A
    Antiviral Res; 2019 Dec; 172():104617. PubMed ID: 31593751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macaque Monoclonal Antibodies Targeting Novel Conserved Epitopes within Filovirus Glycoprotein.
    Keck ZY; Enterlein SG; Howell KA; Vu H; Shulenin S; Warfield KL; Froude JW; Araghi N; Douglas R; Biggins J; Lear-Rooney CM; Wirchnianski AS; Lau P; Wang Y; Herbert AS; Dye JM; Glass PJ; Holtsberg FW; Foung SK; Aman MJ
    J Virol; 2016 Jan; 90(1):279-91. PubMed ID: 26468532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multifunctional Pan-ebolavirus Antibody Recognizes a Site of Broad Vulnerability on the Ebolavirus Glycoprotein.
    Gilchuk P; Kuzmina N; Ilinykh PA; Huang K; Gunn BM; Bryan A; Davidson E; Doranz BJ; Turner HL; Fusco ML; Bramble MS; Hoff NA; Binshtein E; Kose N; Flyak AI; Flinko R; Orlandi C; Carnahan R; Parrish EH; Sevy AM; Bombardi RG; Singh PK; Mukadi P; Muyembe-Tamfum JJ; Ohi MD; Saphire EO; Lewis GK; Alter G; Ward AB; Rimoin AW; Bukreyev A; Crowe JE
    Immunity; 2018 Aug; 49(2):363-374.e10. PubMed ID: 30029854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pan-ebolavirus and Pan-filovirus Mouse Monoclonal Antibodies: Protection against Ebola and Sudan Viruses.
    Holtsberg FW; Shulenin S; Vu H; Howell KA; Patel SJ; Gunn B; Karim M; Lai JR; Frei JC; Nyakatura EK; Zeitlin L; Douglas R; Fusco ML; Froude JW; Saphire EO; Herbert AS; Wirchnianski AS; Lear-Rooney CM; Alter G; Dye JM; Glass PJ; Warfield KL; Aman MJ
    J Virol; 2016 Jan; 90(1):266-78. PubMed ID: 26468533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a Human Antibody Cocktail that Deploys Multiple Functions to Confer Pan-Ebolavirus Protection.
    Wec AZ; Bornholdt ZA; He S; Herbert AS; Goodwin E; Wirchnianski AS; Gunn BM; Zhang Z; Zhu W; Liu G; Abelson DM; Moyer CL; Jangra RK; James RM; Bakken RR; Bohorova N; Bohorov O; Kim DH; Pauly MH; Velasco J; Bortz RH; Whaley KJ; Goldstein T; Anthony SJ; Alter G; Walker LM; Dye JM; Zeitlin L; Qiu X; Chandran K
    Cell Host Microbe; 2019 Jan; 25(1):39-48.e5. PubMed ID: 30629917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgY antibodies against Ebola virus possess post-exposure protection in a murine pseudovirus challenge model and excellent thermostability.
    Zhang Y; Wei Y; Li Y; Wang X; Liu Y; Tian D; Jia X; Gong R; Liu W; Yang L
    PLoS Negl Trop Dis; 2021 Mar; 15(3):e0008403. PubMed ID: 33711011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Broadly neutralizing antibodies from human survivors target a conserved site in the Ebola virus glycoprotein HR2-MPER region.
    Flyak AI; Kuzmina N; Murin CD; Bryan C; Davidson E; Gilchuk P; Gulka CP; Ilinykh PA; Shen X; Huang K; Ramanathan P; Turner H; Fusco ML; Lampley R; Kose N; King H; Sapparapu G; Doranz BJ; Ksiazek TG; Wright DW; Saphire EO; Ward AB; Bukreyev A; Crowe JE
    Nat Microbiol; 2018 Jun; 3(6):670-677. PubMed ID: 29736037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Equine-Origin Immunoglobulin Fragments Protect Nonhuman Primates from Ebola Virus Disease.
    Wang H; Wong G; Zhu W; He S; Zhao Y; Yan F; Rahim MN; Bi Y; Zhang Z; Cheng K; Jin H; Cao Z; Zheng X; Gai W; Bai J; Chen W; Zou Y; Gao Y; Gao GF; Yang S; Xia X; Qiu X
    J Virol; 2019 Mar; 93(5):. PubMed ID: 30541860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ebola virus glycoprotein Fc fusion protein confers protection against lethal challenge in vaccinated mice.
    Konduru K; Bradfute SB; Jacques J; Manangeeswaran M; Nakamura S; Morshed S; Wood SC; Bavari S; Kaplan GG
    Vaccine; 2011 Apr; 29(16):2968-77. PubMed ID: 21329775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective efficacy of neutralizing antibodies against Ebola virus infection.
    Takada A; Ebihara H; Jones S; Feldmann H; Kawaoka Y
    Vaccine; 2007 Jan; 25(6):993-9. PubMed ID: 17055127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study.
    Geisbert TW; Lee AC; Robbins M; Geisbert JB; Honko AN; Sood V; Johnson JC; de Jong S; Tavakoli I; Judge A; Hensley LE; Maclachlan I
    Lancet; 2010 May; 375(9729):1896-905. PubMed ID: 20511019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent neutralizing monoclonal antibodies against Ebola virus infection.
    Zhang Q; Gui M; Niu X; He S; Wang R; Feng Y; Kroeker A; Zuo Y; Wang H; Wang Y; Li J; Li C; Shi Y; Shi X; Gao GF; Xiang Y; Qiu X; Chen L; Zhang L
    Sci Rep; 2016 May; 6():25856. PubMed ID: 27181584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ebolavirus Glycoprotein Fc Fusion Protein Protects Guinea Pigs against Lethal Challenge.
    Konduru K; Shurtleff AC; Bradfute SB; Nakamura S; Bavari S; Kaplan G
    PLoS One; 2016; 11(9):e0162446. PubMed ID: 27622456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Two-Antibody Pan-Ebolavirus Cocktail Confers Broad Therapeutic Protection in Ferrets and Nonhuman Primates.
    Bornholdt ZA; Herbert AS; Mire CE; He S; Cross RW; Wec AZ; Abelson DM; Geisbert JB; James RM; Rahim MN; Zhu W; Borisevich V; Banadyga L; Gunn BM; Agans KN; Wirchnianski AS; Goodwin E; Tierney K; Shestowsky WS; Bohorov O; Bohorova N; Velasco J; Ailor E; Kim D; Pauly MH; Whaley KJ; Alter G; Walker LM; Chandran K; Zeitlin L; Qiu X; Geisbert TW; Dye JM
    Cell Host Microbe; 2019 Jan; 25(1):49-58.e5. PubMed ID: 30629918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal Analysis of the Human B Cell Response to Ebola Virus Infection.
    Davis CW; Jackson KJL; McElroy AK; Halfmann P; Huang J; Chennareddy C; Piper AE; Leung Y; Albariño CG; Crozier I; Ellebedy AH; Sidney J; Sette A; Yu T; Nielsen SCA; Goff AJ; Spiropoulou CF; Saphire EO; Cavet G; Kawaoka Y; Mehta AK; Glass PJ; Boyd SD; Ahmed R
    Cell; 2019 May; 177(6):1566-1582.e17. PubMed ID: 31104840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular characterization of the monoclonal antibodies composing ZMAb: a protective cocktail against Ebola virus.
    Audet J; Wong G; Wang H; Lu G; Gao GF; Kobinger G; Qiu X
    Sci Rep; 2014 Nov; 4():6881. PubMed ID: 25375093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody.
    Corti D; Misasi J; Mulangu S; Stanley DA; Kanekiyo M; Wollen S; Ploquin A; Doria-Rose NA; Staupe RP; Bailey M; Shi W; Choe M; Marcus H; Thompson EA; Cagigi A; Silacci C; Fernandez-Rodriguez B; Perez L; Sallusto F; Vanzetta F; Agatic G; Cameroni E; Kisalu N; Gordon I; Ledgerwood JE; Mascola JR; Graham BS; Muyembe-Tamfun JJ; Trefry JC; Lanzavecchia A; Sullivan NJ
    Science; 2016 Mar; 351(6279):1339-42. PubMed ID: 26917593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of a Therapeutic Antibody Cocktail Reveals Determinants for Cooperative and Broad Ebolavirus Neutralization.
    Gilchuk P; Murin CD; Milligan JC; Cross RW; Mire CE; Ilinykh PA; Huang K; Kuzmina N; Altman PX; Hui S; Gunn BM; Bryan AL; Davidson E; Doranz BJ; Turner HL; Alkutkar T; Flinko R; Orlandi C; Carnahan R; Nargi R; Bombardi RG; Vodzak ME; Li S; Okoli A; Ibeawuchi M; Ohiaeri B; Lewis GK; Alter G; Bukreyev A; Saphire EO; Geisbert TW; Ward AB; Crowe JE
    Immunity; 2020 Feb; 52(2):388-403.e12. PubMed ID: 32023489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies are necessary for rVSV/ZEBOV-GP-mediated protection against lethal Ebola virus challenge in nonhuman primates.
    Marzi A; Engelmann F; Feldmann F; Haberthur K; Shupert WL; Brining D; Scott DP; Geisbert TW; Kawaoka Y; Katze MG; Feldmann H; Messaoudi I
    Proc Natl Acad Sci U S A; 2013 Jan; 110(5):1893-8. PubMed ID: 23319647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.